Catalyst Pharmaceuticals Inc (CPRX) Stock Analysis
Last updated Aug 30, 2026
Health Check
Last analyzed Sep 7, 2026
- Financial Health 70
- Profitability 95
- Business Quality 75
- Balance Sheet 65
- Cash Flow 80
Why this rating?
Health 81/100 — Elite Quality
Worth tracking, but timing is mixed — not a clear setup yet.
Company overview
Catalyst Pharmaceuticals Inc (CPRX) is a Biotechnology company in the Healthcare sector. Compound Radar rates Catalyst Pharmaceuticals Inc 81/100 (Elite Quality) due to high business quality, steady revenue growth, and manageable leverage.
Investment profile
- Quality High
- Growth Moderate
- Balance Sheet Adequate
- Valuation Attractive
Financial highlights
Valuation
- P/E 18.2
- Forward P/E 9.9
- EV/Revenue 5.19
Profitability
- Revenue Growth 5.6%
- Gross Margin 84.0%
- Operating Margin 49.0%
- Net Margin 37.1%
- ROE 24.5%
Financial strength
- Cash $755.86M
- Debt $2.68M
- Net Cash $753.18M
- Free Cash Flow $208.61M
- Current Ratio 7.1
Similar companies
Peers in Biotechnology, ranked by Financial Health.
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- Aurinia Pharmaceuticals Inc. Biotechnology AUPH$16.07 83 Health 83 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Incyte Corporation Biotechnology INCY$124.40 82 Health 82 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Alnylam Pharmaceuticals, Inc. Biotechnology ALNY$260.10 78 Health 78 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Halozyme Therapeutics, Inc. Biotechnology HALO$108.31 77 Health 77 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Vertex Pharmaceuticals Incorporated Biotechnology VRTX$528.90 76 Health 76 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Harmony Biosciences Holdings, Inc. Biotechnology HRMY$42.07 76 Health 76 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- ACADIA Pharmaceuticals Inc. Biotechnology ACAD$27.58 75 Health 75 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- BioMarin Pharmaceutical Inc. Biotechnology BMRN$64.63 74 Health 74 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar scores and tracks Catalyst Pharmaceuticals Inc (CPRX).